The Company owns a 60,000-square foot pharmaceutical production facility located in Pessac, France.

The Pessac facility and its operation are approved by the European drug agencies and are in substantial compliance with "Good Manufacturing Practice" ("cGMP"). The facility provides Flamel with the capability to manufacture its cGMP-grade pharmaceutical drugs for clinical trials utilizing its Micropump® or Medusa® technologies.